Norveç -
Norveççe -
Statens legemiddelverk
thallous (201ti) chloride 37 mbq/ ml
curium netherlands b.v. - talliumklorid (201tl) - injeksjonsvæske, oppløsning - 37 mbq/ ml
Norveç -
Norveççe -
Statens legemiddelverk
teceos 13 mg
cis bio international - butedronatetetranatrium - preparasjonssett til radioaktive legemidler - 13 mg
Norveç -
Norveççe -
Statens legemiddelverk
technescan dtpa -
curium netherlands b.v. - kalsiumtrinatriumpentetat - preparasjonssett til radioaktive legemidler
Norveç -
Norveççe -
Statens legemiddelverk
nanocis 0.15 mg
cis bio international - rheniumsulfid - injeksjonsvæske, oppløsning - 0.15 mg
Avrupa Birliği -
Norveççe -
EMA (European Medicines Agency)
celsunax
pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. hos voksne pasienter, for å kunne skille mellom sannsynlig demens med lewy legemer fra alzheimers sykdom. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
